Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity

Edith Wing-Kar Chow, Elaine Chow

Open source

DOI
10.1016/s0140-6736(25)02381-5
Published
2025-12
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-02381-5,
  title = {Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity},
  author = {Edith Wing-Kar Chow and Elaine Chow},
  year = {2025},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(25)02381-5},
  url = {https://doi.org/10.1016/s0140-6736(25)02381-5}
}

RIS

TY  - JOUR
TI  - Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity
AU  - Edith Wing-Kar Chow
AU  - Elaine Chow
PY  - 2025
JO  - The Lancet
DO  - 10.1016/s0140-6736(25)02381-5
UR  - https://doi.org/10.1016/s0140-6736(25)02381-5
ER  - 

APA

Chow, E. W., & Chow, E. (2025). Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity. The Lancet. https://doi.org/10.1016/s0140-6736(25)02381-5

Source records